185 related articles for article (PubMed ID: 28119492)
1. Correlation of
Yang HW; Wang YX; Bao J; Wang SH; Lei P; Sun ZL
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28119492
[TBL] [Abstract][Full Text] [Related]
2. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
3. [The relevance of tumor necrosis factor-alpha gene-863C/A polymorphism with thyroid-associated ophthalmopathy].
Yan SL; Wang YX
Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):786-90. PubMed ID: 16191343
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.
Yousefipour GA; Salami Z; Farjadian S
Iran J Immunol; 2009 Jun; 6(2):99-102. PubMed ID: 19561379
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report.
Ma R; Cheng Y; Gan L; Zhou X; Qian J
BMC Ophthalmol; 2020 Apr; 20(1):166. PubMed ID: 32321476
[TBL] [Abstract][Full Text] [Related]
6. [HLA-DQ molecules associated with myasthenia gravis in Chinese patients].
Li X; Zhang KX; Fan YX; Chen XZ; Zuo J; Pan XH; Zhu DL; Geng ZC
Yi Chuan Xue Bao; 1999; 26(4):295-300. PubMed ID: 10593018
[TBL] [Abstract][Full Text] [Related]
7. Correlations of TNF-α gene promoter polymorphisms with the risk of thymoma-associated myasthenia gravis in a northern Chinese Han population.
Yang HW; Lei P; Xie YC; Han ZL; Li D; Wang SH; Sun ZL
Cancer Gene Ther; 2017 Jun; 24(6):259-266. PubMed ID: 28429750
[TBL] [Abstract][Full Text] [Related]
8. HLA-DQ polymorphism in Turkish patients with myasthenia gravis.
Saruhan-Direskeneli G; Kiliç A; Parman Y; Serdaroğlu P; Deymeer F
Hum Immunol; 2006; 67(4-5):352-8. PubMed ID: 16720217
[TBL] [Abstract][Full Text] [Related]
9. Trans-encoded DQ alpha beta heterodimers confer susceptibility to myasthenia gravis disease.
Khalil I; Berrih-Aknin S; Lepage V; Loste MN; Gajdos P; Hors J; Charron D; Degos L
C R Acad Sci III; 1993 Jul; 316(7):652-60. PubMed ID: 8019886
[TBL] [Abstract][Full Text] [Related]
10. Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis.
Hjelmström P; Giscombe R; Lefvert AK; Pirskanen R; Kockum I; Landin-Olsson M; Sanjeevi CB
Autoimmunity; 1995; 22(1):59-65. PubMed ID: 8882423
[TBL] [Abstract][Full Text] [Related]
11. Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States.
Deitiker PR; Oshima M; Smith RG; Mosier D; Atassi MZ
Int J Immunogenet; 2011 Feb; 38(1):55-62. PubMed ID: 21108743
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA-DR/DQ polymorphism with myasthenia gravis in Tunisian patients.
Fekih-Mrissa N; Klai S; Zaouali J; Gritli N; Mrissa R
Clin Neurol Neurosurg; 2013 Jan; 115(1):32-6. PubMed ID: 22521184
[TBL] [Abstract][Full Text] [Related]
13. A new mouse model of autoimmune ocular myasthenia gravis.
Yang H; Wu B; Tüzün E; Saini SS; Li J; Allman W; Higgs S; Xiao TL; Christadoss P
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5101-11. PubMed ID: 17962462
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis.
Hjelmström P; Giscombe R; Lefvert AK; Pirskanen R; Kockum I; Landin-Olsson M; Sanjeevi CB
J Neuroimmunol; 1996 Apr; 65(2):125-31. PubMed ID: 8964894
[TBL] [Abstract][Full Text] [Related]
15. Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis.
Deitiker PR; Oshima M; Smith RG; Mosier DR; Atassi MZ
Autoimmunity; 2006 Jun; 39(4):277-88. PubMed ID: 16891216
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis.
Raju R; Zhan WZ; Karachunski P; Conti-Fine B; Sieck GC; David C
J Immunol; 1998 May; 160(9):4169-74. PubMed ID: 9574516
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population.
Ehsan S; Amirzargar A; Yekaninejad MS; Mahmoudi M; Mehravar S; Moradi B; Nafissi S
J Neurol Sci; 2015 Dec; 359(1-2):335-42. PubMed ID: 26671138
[TBL] [Abstract][Full Text] [Related]
18. [HLA-DQB1 allele polymorphism and clinical characteristics of 15 familial myasthenia gravis cases in north China].
Yang HW; Sun ZL; Zhang MY; Wang SH; Li HF; Cong ZQ; Gao XY; Xie YC
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):437-9. PubMed ID: 16883535
[TBL] [Abstract][Full Text] [Related]
19. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region.
Hjelmström P; Peacock CS; Giscombe R; Pirskanen R; Lefvert AK; Blackwell JM; Sanjeevi CB
Ann N Y Acad Sci; 1998 May; 841():368-70. PubMed ID: 9668261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
